Paperpal Prime Logo

Journal of Pharmacology and Experimental Therapeutics : Impact Factor & More

eISSN: 1521-0103pISSN: 0022-3565

Key Metrics

CiteScore
7.1
Impact Factor
< 5
SNIP
1.04
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Pharmacology and Experimental Therapeutics

Journal of Pharmacology and Experimental Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1909
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Pharmacology and Experimental Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Pharmacology and Experimental Therapeutics

Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
  • 28 Jan 2027
  • The Journal of pharmacology and experimental therapeutics
Keeping it acid ceramidase: How adiponectin protects in the glomerulus.
  • 27 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges.
  • 14 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Cardiac homing peptide-decorated epigallocatechin gallate-loaded poly(lactic-co-glycolic acid) nanoparticles alleviate acute myocardial infarction.
  • 14 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.
  • 9 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
M1 muscarinic receptor modulation drives sex-specific alterations of Alzheimer's pathophysiology in APPswe/PSEN1ΔE9 mice.
  • 9 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
  • 28 Jan 2027
  • The Journal of pharmacology and experimental therapeutics
Keeping it acid ceramidase: How adiponectin protects in the glomerulus.
  • 27 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges.
  • 14 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Cardiac homing peptide-decorated epigallocatechin gallate-loaded poly(lactic-co-glycolic acid) nanoparticles alleviate acute myocardial infarction.
  • 14 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.
  • 9 Jul 2026
  • The Journal of pharmacology and experimental therapeutics
M1 muscarinic receptor modulation drives sex-specific alterations of Alzheimer's pathophysiology in APPswe/PSEN1ΔE9 mice.
  • 9 Jul 2026
  • The Journal of pharmacology and experimental therapeutics

FAQs on Journal of Pharmacology and Experimental Therapeutics